Suggestive evidence of hepatotoxicity concomitant with thioridazine hydrochloride use.
D000410:Alanine Transaminase / Q000378:metabolism; D000469:Alkaline Phosphatase / Q000378:metabolism; D001219:Aspartate Aminotransferases / Q000378:metabolism; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D002746:Chlorpromazine / Q000009:adverse effects; D004342:Drug Hypersensitivity; D005221:Fatigue / Q000209:etiology; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D010787:Photosensitivity Disorders / Q000209:etiology; D011537:Pruritus / Q000209:etiology; D013881:Thioridazine / Q000009:adverse effects*
D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D013881:Thioridazine; D002746:Chlorpromazine